These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 19669878)

  • 41. Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses.
    Corley DA; Kubo A; DeBoer J; Rumore GJ
    Gastrointest Endosc; 2009 May; 69(6):1004-10. PubMed ID: 19152897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.
    Gopal DV; Lieberman DA; Magaret N; Fennerty MB; Sampliner RE; Garewal HS; Falk GW; Faigel DO
    Dig Dis Sci; 2003 Aug; 48(8):1537-41. PubMed ID: 12924649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A guide for surveillance of patients with Barrett's esophagus.
    Provenzale D; Kemp JA; Arora S; Wong JB
    Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Barrett's esophagus and Barrett's-related dysplasia.
    Goldblum JR
    Mod Pathol; 2003 Apr; 16(4):316-24. PubMed ID: 12692197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endoscopic follow-up of Barrett's esophagus: protocol and implications.
    De Looze D
    Acta Gastroenterol Belg; 2000; 63(1):29-35. PubMed ID: 10907316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.
    Falk GW; Rice TW; Goldblum JR; Richter JE
    Gastrointest Endosc; 1999 Feb; 49(2):170-6. PubMed ID: 9925694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
    Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE;
    United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.
    Miros M; Kerlin P; Walker N
    Gut; 1991 Dec; 32(12):1441-6. PubMed ID: 1773946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Qualitative mapping of Barrett's metaplasia: a prerequisite for intervention trials.
    Eisen GM; Montgomery EA; Azumi N; Hartmann DP; Bhargava P; Lippman M; Benjamin SB
    Gastrointest Endosc; 1999 Dec; 50(6):814-8. PubMed ID: 10570342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
    Incarbone R; Bonavina L; Saino G; Bona D; Peracchia A
    Surg Endosc; 2002 Feb; 16(2):263-6. PubMed ID: 11967675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.
    Coleman HG; Bhat SK; Murray LJ; McManus DT; O'Neill OM; Gavin AT; Johnston BT
    Am J Gastroenterol; 2014 Apr; 109(4):527-34. PubMed ID: 24589668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.
    Weston AP; Sharma P; Mathur S; Banerjee S; Jafri AK; Cherian R; McGregor D; Hassanein RS; Hall M
    Am J Gastroenterol; 2004 Sep; 99(9):1657-66. PubMed ID: 15330898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barrett's esophagus: a surgical disease.
    Patti MG; Arcerito M; Feo CV; Worth S; De Pinto M; Gibbs VC; Gantert W; Tyrrell D; Ferrell LF; Way LW
    J Gastrointest Surg; 1999; 3(4):397-403; discussion 403-4. PubMed ID: 10482692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of adenocarcinoma among patients with Barrett's esophagus.
    Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
    N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
    Rusch VW; Levine DS; Haggitt R; Reid BJ
    Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surveillance of Barrett's esophagus: a need for guidelines?
    Ackroyd R; Wakefield SE; Williams JL; Stoddard CJ; Reed MW
    Dis Esophagus; 1997 Jul; 10(3):185-9. PubMed ID: 9280077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.
    Yousef F; Cardwell C; Cantwell MM; Galway K; Johnston BT; Murray L
    Am J Epidemiol; 2008 Aug; 168(3):237-49. PubMed ID: 18550563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
    Heitmiller RF; Redmond M; Hamilton SR
    Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.
    Lee RG
    Am J Surg Pathol; 1985 Dec; 9(12):845-52. PubMed ID: 2416226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The economic impact of the diagnosis of dysplasia in Barrett's esophagus.
    Ofman JJ; Lewin K; Ramers C; Ippoliti A; Lieberman D; Weinstein W
    Am J Gastroenterol; 2000 Oct; 95(10):2946-52. PubMed ID: 11051373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.